Atrial flutter in patients treated for atrial fibrillation with propafenone

Electrophysiological and Antiarrhythmic Properties of Propafenon in Isolated Cardiac Preparations

Ledda, F., Mantelli, L., Manzini, S., Amerini, S., & Mugelli, A. (1981) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198111000-00002 · Cited by 126 · see citing works

Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatment

Crijns, H. J., van Gelder, I. C., & Lie, K. I. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)90282-2 · Cited by 120 · see citing works

Long-term oral propafenone therapy for suppression of refractory symptomatic atrial fibrillation and atrial flutter

Antman, E. M., Beamer, A. D., Cantillon, C. O., McGowan, N. E., Goldman, L., & Friedman, P. L. (1988) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(88)90468-8 · Cited by 116 · see citing works

Correlation between serum concentration and pharmacological effect on atrioventricular conduction time of the antiarrhythmic drug propafenone

Keller, K., Meyer-Estorf, G., Beck, O. A., & Hochrein, H. A. (1978) · European Journal of Clinical Pharmacology · doi:10.1007/bf00606676 · Cited by 65 · see citing works

Propafenone for paroxysmal atrial fibrillation

Hammill, S. C., Wood, D. L., Gersh, B. J., Osborn, M. J., & Holmes, D. R. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)90312-8 · Cited by 65 · see citing works

Propafenone for prevention of recurrent atrial fibrillation

Kerr, C. R., Klein, G. J., Axelson, J. E., & Cooper, J. C. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)90373-6 · Cited by 62 · see citing works

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS).

Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J., Blomström-Lundqvist, C., Boriani, G., Castellá, M., Dan, G., Dilaveris, P. E., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 2,605 · see citing works

2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC)

Brugada, J., Katritsis, D. G., Arbelo, E., Arribas, F., Bax, J. J., Blomström‐Lundqvist, C., Calkins, H. G., Corrado, D., Deftereos, S. G., Diller, G., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz467 · Cited by 1,278 · see citing works

Prevalence, mechanisms, and clinical significance of macroreentrant atrial tachycardia during and following left atrial ablation for atrial fibrillation

Chugh, A., Oral, H., Lemola, K., Hall, B., Cheung, P., Good, E., Tamirisa, K., Han, J., Bogun, F., Pelosi, F., et al. (2005) · Heart Rhythm · doi:10.1016/j.hrthm.2005.01.027 · Cited by 338 · see citing works

Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension

Capucci, A., Lenzi, T., Boriani, G., Trisolino, G., Binetti, N., Cavazza, M., Fontana, G. A., & Magnani, B. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91392-h · Cited by 227 · see citing works

Gender-related differences in catheter ablation of atrial fibrillation

Forleo, G. B., Tondo, C., De Luca, L., Russo, A. D., Casella, M., De Sanctis, V., Clementi, F., Fagundes, R. L., Leo, R., Romeo, F., et al. (2007) · EP Europace · doi:10.1093/europace/eum144 · Cited by 189 · see citing works

European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE)

Katritsis, D. G., Boriani, G., Cosio, F. G., Hindricks, G., Jaïs, P., Josephson, M. E., Keegan, R., Kim, Y.-H., Knight, B. P., Kuck, K.-H., et al. (2017) · Europace · doi:10.1093/europace/euw301 · Cited by 188 · see citing works

Proarrhythmia in Patients Treated for Atrial Fibrillation or Flutter

Falk, R. H. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-2-141 · Cited by 184 · see citing works

Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide

Capucci, A., Boriani, G., Botto, G. L., Lenzi, T., Rubino, I., Falcone, C., Trisolino, G., Casa, S. D., Binetti, N., Cavazza, M., et al. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90915-6 · Cited by 172 · see citing works

Effects of Oral Propafenone Administration Before Electrical Cardioversion of Chronic Atrial Fibrillation: A Placebo-Controlled Study

Bianconi, L., Mennuni, M., Lukic, V., Castro, A., Chieffi, M., & Santini, M. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)00230-6 · Cited by 165 · see citing works

Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation

Capucci, A. (2000) · European Heart Journal · doi:10.1053/euhj.1999.1734 · Cited by 155 · see citing works

A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm

Capucci, A., Boriani, G., Rubino, I., Casa, S. D., Sanguinetti, M., & Magnani, B. (1994) · International Journal of Cardiology · doi:10.1016/0167-5273(94)90211-9 · Cited by 127 · see citing works

Radiofrequency Catheter Ablation of Common Atrial Flutter

Anselme, F., Saoudi, N. C., Poty, H., Douillet, R., & Cribier, A. G. (1999) · Circulation · doi:10.1161/01.cir.99.4.534 · Cited by 121 · see citing works

Propafenone for Conversion of Recent-Onset Atrial Fibrillation

Boriani, G., Capucci, A., Lenzi, T., Sanguinetti, M., & Magnani, B. (1995) · CHEST Journal · doi:10.1378/chest.108.2.355 · Cited by 110 · see citing works

Catheter Ablation of Atypical Atrial Flutter and Atrial Tachycardia Within the Coronary Sinus After Left Atrial Ablation for Atrial Fibrillation

Chugh, A., Oral, H., Good, E. D., Han, J. D., Tamirisa, K. P., Lemola, K., Elmouchi, D., Tschopp, D. R., Reich, S., Igic, P., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.03.053 · Cited by 107 · see citing works

Value of single oral loading dose of propafenone in converting recent-onset atrial fibrillation: Results of a randomized, double-blind, controlled study

Azpitarte, J., Alvarez, M., Baun, R. F., García, R., Moreno, E., Martin, F., Tercedor, L., & Fernandez, R. (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015146 · Cited by 105 · see citing works

Thromboembolism in Chronic Atrial Flutter: Is the Risk Underestimated?

Lanzarotti, C. J., & Olshansky, B. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00326-4 · Cited by 103 · see citing works

The Treatment of Atrial Fibrillation

Nattel, S., Hadjis, T., & Talajic, M. R. (1994) · Drugs · doi:10.2165/00003495-199448030-00003 · Cited by 102 · see citing works

Radiofrequency ablation of atrial flutter due to administration of class IC antiarrhythmic drugs for atrial fibrillation

Schumacher, B. M., Jung, W., Lewalter, T., Vahlhaus, C., Wolpert, C., & Lüderitz, B. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00975-8 · Cited by 101 · see citing works

Conversion of Recent-Onset Atrial Fibrillation by a Single Oral Dose of Pilsicainide ( Pilsicainide Suppression Trial on Atrial Fibrillation)

Atarashi, H., Inoue, H., Hiejima, K., & Hayakawa, H. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00401-8 · Cited by 100 · see citing works

Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation

Siu, C.-W., Lau, C.-P., Lee, W.-L., Lam, K.-F., & Tse, H.-F. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181a02f56 · Cited by 96 · see citing works

Pharmacological Cardioversion of Atrial Fibrillation

Boriani, G., Diemberger, I., Biffi, M., Martignani, C., & Branzi, A. (2004) · Drugs · doi:10.2165/00003495-200464240-00003 · Cited by 91 · see citing works

Propafenone

Bryson, H. M., Palmer, K. J., Langtry, H. D., & Fitton, A. (1993) · Drugs · doi:10.2165/00003495-199345010-00008 · Cited by 78 · see citing works

Conversion of recent onset atrial fibrillation to sinus rhythm using a single oral loading dose of propafenone: comparison of two regimens

Botto, G. L., Capucci, A., Bonini, W., Boriani, G., BROFFONI, T., Barone, P., Espureo, M., Lombardi, R., Molteni, S., & Ferrari, G. M. (1997) · International Journal of Cardiology · doi:10.1016/s0167-5273(96)02841-0 · Cited by 77 · see citing works

Safety of oral propafenone in the conversion of recent onset atrial fibrillation to sinus rhythm:

Capucci, A., VILLANI, G. Q., Aschieri, D., & Piepoli, M. F. (1999) · International Journal of Cardiology · doi:10.1016/s0167-5273(98)00363-5 · Cited by 71 · see citing works

Proarrhythmia

Friedman, P. L., & Stevenson, W. G. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00586-4 · Cited by 70 · see citing works

Comparison of oral loading dose of propafenone and amiodarone for converting recent-onset atrial fibrillation

Blanc, J., Voinov, C., & Maarek, M. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00493-2 · Cited by 69 · see citing works

The hazards of using type 1C antiarrhythmic drugs for the treatment of paroxysmal atrial fibrillation

Marcus, G. M. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90851-q · Cited by 69 · see citing works

Comparison between propafenone and digoxin administered intravenously to patients with acute atrial fibrillation

Bianconi, L., & Mennuni, M. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00412-3 · Cited by 62 · see citing works

Effectiveness of intravenous propafenone for conversion of recent‐onset atrial fibrillation: A placebo‐controlled study

Bellandi, F., Cantini, F., Pedone, T., Palchetti, R., Bamoshmoosh, M., & Dabizzi, R. P. (1995) · Clinical Cardiology · doi:10.1002/clc.4960181108 · Cited by 62 · see citing works

Persistent Atrial Flutter in Patients Treated for Atrial Fibrillation with Amiodarone and Propafenone: Electrophysiologic Characteristics, Radiofrequency Catheter Ablation, and Risk Prediction

TAI, C., CHIANG, C., LEE, S., CHEN, Y., YU, W., FENG, A., DING, Y., CHANG, M., & CHEN, S. (1999) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1999.tb00293.x · Cited by 60 · see citing works

The Alternation between Atrial Flutter and Atrial Fibrillation

Tunick, P. A., McElhinney, L., Mitchell, T., & Kronzon, I. (1992) · CHEST Journal · doi:10.1378/chest.101.1.34 · Cited by 57 · see citing works

Predictors of atrial flutter with 1:1 conduction in patients treated with class I antiarrhythmic drugs for atrial tachyarrhythmias

Brembilla-Perrot, B., Houriez, P., Beurrier, D., Claudon, O., Chaise, A. T. D. L., & Louis, P. (2001) · International Journal of Cardiology · doi:10.1016/s0167-5273(01)00459-4 · Cited by 56 · see citing works

Regular Ventricular Rhythms Before Conversion of Recent Onset Atrial Fibrillation to Sinus Rhythm

Botto, G., Bonini, W., BROFFONI, T., CAPPELLETTI, G. A., Falcone, C., LOMBARDI, R., Paulesu, A., PEDRAGLIO, E., & Ferrari, G. M. (1994) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1994.tb03810.x · Cited by 56 · see citing works

Clinical Pharmacokinetics of Propafenone

Hii, J. T. Y., Duff, H. J., & Burgess, E. D. (1991) · Clinical Pharmacokinetics · doi:10.2165/00003088-199121010-00001 · Cited by 55 · see citing works

Comparisons of Oral Propafenone and Sotalol as an Initial Treatment in Patients With Symptomatic Paroxysmal Atrial Fibrillation

Lee, S.-H., Chen, S., TAI, C., Chiang, C., Wen, Z., Chen, Y., Yu, W., Huang, J., Fong, A.-N., Cheng, J.-J., et al. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00025-8 · Cited by 54 · see citing works

Acute Treatment of Atrial Fibrillation

Kowey, P. R., Marinchak, R. A., Rials, S. J., & Filart, R. A. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00182-9 · Cited by 53 · see citing works

Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination

Biffi, M., Boriani, G., Bronzetti, G., Capucci, A., Branzi, A., & Magnani, B. (1999) · Heart · doi:10.1136/hrt.82.2.176 · Cited by 47 · see citing works

Response to flecainide infusion predicts long-term success of hybrid pharmacologic and ablation therapy in patients with atrial fibrillation

Stabile, G., De Simone, A., Turco, P., La Rocca, V., Nocerino, P., Astarita, C., Maresca, F., De Matteis, C., Di Napoli, T., Stabile, E., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01214-1 · Cited by 46 · see citing works

Effects of diltiazem pretreatment on direct-current cardioversion in patients with persistent atrial fibrillation: A single-blind, randomized, controlled study

VILLANI, G. Q., Piepoli, M. F., Terracciano, C. M., & Capucci, A. (2000) · American Heart Journal · doi:10.1067/mhj.2000.107179 · Cited by 44 · see citing works

Conversion of Recent Onset Atrial Fibrillation with Single Loading Oral Dose of Propafenone: Is In‐Hospital Admission Absolutely Necessary?

Botto, G. L., Bonini, W., BROFFONI, T., Molteni, S., LOMBARDI, R., ALFIERI, G., Barone, P., Bernasconi, G., & Ferrari, G. M. (1996) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1996.tb03257.x · Cited by 44 · see citing works

Antiarrhythmic Drug Therapy in the Management of Atrial Fibrillation

Ganz, L. I., & Antman, E. M. (1997) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1997.tb01005.x · Cited by 38 · see citing works

Randomized, Crossover, Controlled Comparison of Oral Loading Versus Intravenous Infusion of Propafenone in Recent‐Onset Atrial Fibrillation

Botto, G. L., Bonini, W., BROFFONI, T., Espureo, M., CAPPELLETTI, G. A., Lombardi, R., Molteni, S., PEDRAGLIO, E., & Ferrari, G. M. (1998) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1998.tb01205.x · Cited by 36 · see citing works

Propafenone in the Treatment of Cardiac Arrhythmias

Capucci, A., & Boriani, G. (1995) · Drug Safety · doi:10.2165/00002018-199512010-00005 · Cited by 35 · see citing works

Risk of Complications of Atrial Fibrillation

Capucci, A., VILLANI, G. Q., & Aschieri, D. (1997) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1997.tb06117.x · Cited by 33 · see citing works

Oral Loading with Propafenone for Conversion of Recent-Onset Atrial Fibrillation

Boriani, G., Martignani, C., Biffi, M., Capucci, A., & Branzi, A. (2002) · Drugs · doi:10.2165/00003495-200262030-00001 · Cited by 30 · see citing works

New Approaches to Treatment of Atrial Flutter and Tachycardia

Lesh, M. D., Kalman, J. M., & Olgin, J. E. (1996) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1996.tb00539.x · Cited by 31 · see citing works

Limitations to antiarrhythmic drug use in patients with atrial fibrillation

Humphries, K. H. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1031277 · Cited by 30 · see citing works

Syncope in patients with atrial flutter during treatment with class Ic antiarrhythmic drugs

Kawabata, M., Hirao, K., Horikawa, T., Suzuki, K., Motokawa, K., Suzuki, F., Azegami, K., & Hiejima, K. (2001) · Journal of Electrocardiology · doi:10.1054/jelc.2001.22034 · Cited by 29 · see citing works

Guía ESC 2020 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración de la European Association of Cardio-Thoracic Surgery (EACTS)

Hindricks, G., Potpara, T. S., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., Boriani, G., Castellá, M., Dan, G., Dilaveris, P. E., et al. (2021) · Revista Española de Cardiología · doi:10.1016/j.recesp.2020.10.022 · Cited by 24 · see citing works

Atypical atrial flutter: clinical features, electrophysiological characteristics and response to radiofrequency catheter ablation

Bella, P. E. D. (2002) · EP Europace · doi:10.1053/eupc.2002.0242 · Cited by 27 · see citing works

Incidence and clinical significance of transformation of atrial fibrillation to atrial flutter in patients undergoing long-term antiarrhythmic drug treatment

Riva, S. I. (1999) · EP Europace · doi:10.1053/eupc.1999.0048 · Cited by 25 · see citing works

Outcome after cavo-tricuspid isthmus ablation in patients with recurrent atrial fibrillation and drug-related typical atrial flutter

Bottoni, N., Donateo, P., Quartieri, F., Tomasi, C., Oddone, D., Lolli, G., Menozzi, C., & Brignole, M. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.04.069 · Cited by 24 · see citing works

Propafenone: An Effective Agent for the Management of Supraventricular Arrhythmias

Grant, A. O. (1996) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1996.tb00537.x · Cited by 23 · see citing works

Intravenous propafenone: Efficacy and safety in the conversion to sinus rhythm of recent onset atrial fibrillation—A single-blind placebo-controlled study

Bellandi, F., Dabizzi, R. P., Cantini, F., Natale, M., & Niccoli, L. (1996) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00823593 · Cited by 23 · see citing works

Atypical atrial flutter: review of mechanisms, advances in mapping and ablation outcomes

Ko, N. L. K., Sriramoju, A., Khetarpal, B. K., & Srivathsan, K. (2021) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000924 · Cited by 21 · see citing works

Atrial fibrillation after typical atrial flutter ablation: a long-term follow-up

Bandini, A., Golia, P., Caroli, E., Biancoli, S., & Galvani, M. (2011) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e3283403301 · Cited by 20 · see citing works

Drug-induced atrial fibrillation. A narrative review of a forgotten adverse effect

Tamargo, J. L., Pérez‐Villacastín, J., Caballero, R., & Delpón, E. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107077 · Cited by 22 · see citing works

Placebo-controlled evaluations of propafenone for atrial tachyarrhythmias

Rae, A. P. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00739-5 · Cited by 19 · see citing works

The treatment of atrial fibrillation: Pharmacologic and nonpharmacologic strategies

Viskin, S., Barron, H. V., Heller, K., Scheinman, M. M., & Olgin, J. E. (1997) · Current Problems in Cardiology · doi:10.1016/s0146-2806(97)80014-x · Cited by 19 · see citing works

Time-dependent antiarrhythmic effects of flecainide on induced atrial fibrillation in horses

Carstensen, H., Hesselkilde, E. M., Fenner, M. F., Loft‐Andersen, A. V., Flethøj, M., Kanters, J. K., Sattler, S. M., Tfelt‐Hansen, J., Pehrson, S. M., Jespersen, T., et al. (2018) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15287 · Cited by 18 · see citing works

THE MEDICAL MANAGEMENT OF ATRIAL FIBRILLATION

Masoudi, F. A., & Goldschlager, N. (1997) · Cardiology Clinics · doi:10.1016/s0733-8651(05)70370-2 · Cited by 17 · see citing works

Antiarrhythmic drug initiation in patients with atrial fibrillation

Pinski, S. L., & Helguera, M. E. (1999) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(99)70010-1 · Cited by 14 · see citing works

A comparison of propafenone and amiodarone in reversion of recent-onset atrial fibrillation to sinus rhythm

Negrini, M., Gibelli, G., & Ponti, C. D. (1994) · Current Therapeutic Research · doi:10.1016/s0011-393x(05)80319-4 · Cited by 13 · see citing works

Intravenous antiarrhythmic agents

Pintér, A., & Dorian, P. (2001) · Current Opinion in Cardiology · doi:10.1097/00001573-200101000-00003 · Cited by 13 · see citing works

Clinical Pharmacology of Antiarrhythmic Drugs

Capucci, A., Aschieri, D., & VILLANI, G. Q. (1998) · Drugs & Aging · doi:10.2165/00002512-199813010-00006 · Cited by 12 · see citing works

Oral antiarrhythmic drugs in converting recent onset atrial fibrillation

Deneer, V. H. M., Borgh, M. B. I., Kingma, J. H., Lie‐A‐Huen, L., & Brouwers, J. R. B. J. (2004) · Pharmacy World & Science · doi:10.1023/b:phar.0000018593.02291.c0 · Cited by 12 · see citing works

Drugs after Cardioversion to Prevent Relapses of Chronic Atrial Fibrillation or Flutter

Crijns, H. J. G. M., Gosselink, A. T. M., Gelder, I. C. V., Wiesfeld, A. C. P., van den Berg, M. P., Tuininga, Y. S., & Lie, K. I. (1992) · Developments in cardiovascular medicine · doi:10.1007/978-94-011-1816-3_7 · Cited by 11 · see citing works

Selection of patients with secundum atrial septal defects for transcather device closure

Qureshi, S. A. (2000) · European Heart Journal · doi:10.1053/euhj.1999.1972 · Cited by 11 · see citing works

Electrocardiographic and Electrophysiological Characteristics of Atrial Fibrillation Organized Into Atrial Flutter by Oral Administration of Class I Antiarrhythmic Agents

Ohmura, K., Kobayashi, Y., Miyauchi, Y., Endoh, Y., Atarashi, H., Katoh, T., & Takano, T. (2003) · Pacing and Clinical Electrophysiology · doi:10.1046/j.1460-9592.2003.00119.x · Cited by 8 · see citing works

Executive Summary: European Heart Rhythm Association Consensus Document on the Management of Supraventricular Arrhythmias

Katritsis, D. G., Boriani, G., Cosío, F. G., Jaı̈s, P., Hindricks, G., Josephson, M. E., Keegan, R., Knight, B. P., Kück, K., Lane, D. A., et al. (2016) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2016:5.3.gl1 · Cited by 7 · see citing works

Rapid Ventricular Response Due to Treatment of Atrial Flutter or Fibrillation with Class IC Antiarrhythmic Drugs

Mackstaller, L. L., & Marcus, G. M. (2000) · Annals of Noninvasive Electrocardiology · doi:10.1111/j.1542-474x.2000.tb00254.x · Cited by 7 · see citing works

Long‐term efficacy of hybrid pharmacologic and ablation therapy in patients with pilsicainide‐induced atrial flutter

Hirao, K., Okishige, K., Yamamoto, N., Otomo, K., Azegami, K., & Isobe, M. (2005) · Clinical Cardiology · doi:10.1002/clc.4960280707 · Cited by 7 · see citing works

New Options for Pharmacological Conversion of Atrial Fibrillation

Boriani, G. (2001) · Cardiac Electrophysiology Review · doi:10.1023/a:1011488918280 · Cited by 6 · see citing works

Intravenous Propafenone for Conversion of Atrial Fibrillation or Flutter to Sinus Rhythm: A Randomized, Placebo-controlled, Crossover Study

Fak, A. S., Tezcan, H., Caymaz, O., Tokay, S., Oktay, Ş., & Oktay, A. A. (1997) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/107424849700200403 · Cited by 6 · see citing works

Positive inotropic drugs and drugs used in dysrhythmias

Aronson, J. K. (2004) · Side effects of drugs annual · doi:10.1016/s0378-6080(04)80024-2 · Cited by 6 · see citing works

Clinical Characteristics of Atrial Flutter and Its Response to Pharmacological Cardioversion with Amiodarone in Comparison to Atrial Fibrillation

Wybraniec, M. T., Górny, K., Jabłoński, K., Jung, J., Rabtsevich, K., Szyszka, P., Wesołek, F., Bula, K., Cichoń, M., Wróbel, W., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12134262 · Cited by 5 · see citing works

Pharmacological cardioversion of atrial fibrillation: practical considerations

Wybraniec, M. T., Kampka, Z., & Mizia­‐Stec, K. (2023) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.16547 · Cited by 6 · see citing works

Non-Invasive Characteristics of Atrial Fibrillation: The Value of Holter Recordings for the Treatment of AF

WIJFFELS, M. C. E. F., & Crijns, H. J. G. M. (2002) · Cardiac Electrophysiology Review · doi:10.1023/a:1016324908012 · Cited by 5 · see citing works

Management of superior vena caval obstruction secondary to a pacing wire with percutaneous intravascular stent insertion

Melikian, N., Brookes, C. I. O., & Rickards, A. F. (1999) · Heart · doi:10.1136/hrt.82.2.182 · Cited by 5 · see citing works

Evaluación de la fibrilación auricular mediante electrocardiograma y Holter

Mora-Pabón, G. (2016) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2016.10.006 · Cited by 4 · see citing works

Hybrid Therapy in the Management of Atrial Fibrillation

Stárek, Z., Lehár, F., Jež, J., Wolf, J., & Novák, M. (2014) · Current Cardiology Reviews · doi:10.2174/1573403x10666140713172231 · Cited by 3 · see citing works

Aggravation of Arrhythmia by Antiarrhythmic Drugs (Proarrhythmia)

Podrid, P. J. (2010) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2010.06.006 · Cited by 3 · see citing works

Plasma viscosity, fibrinogen, white cell count, and cardiovascular risk factors.

Jay, R. H., RAMPLING, M. W., & Betteridge, D. J. (1992) · Circulation · doi:10.1161/circ.85.5.1572057 · Cited by 3 · see citing works

Management of Intermittent Atrial Fibrillation

Olgin, J. E., & VISKIN, S. (1999) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1999.tb00697.x · Cited by 3 · see citing works

Medikamentöse Kardioversion von Vorhofflimmern

Ehrlich, J. R., & Hohnloser, S. H. (2005) · Zeitschrift für Kardiologie · doi:10.1007/s00392-005-0166-9 · Cited by 3 · see citing works

Positive inotropic drugs and drugs used in dysrhythmias

Aronson, J. K. (1992) · Side effects of drugs annual · doi:10.1016/s0378-6080(05)80498-2 · Cited by 3 · see citing works

Diretriz Brasileira de Fibrilação Atrial – 2025

Cintra, F. D., Pisani, C., Rezende, A. G. D. S., Henz, B. D., Armaganijan, L., Pimentel, M., Lopes, R. D., Nascimento, T. A. D., Lorga, A., de Albuquerque, A. L. T., et al. (2025) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20250618 · Cited by 4 · see citing works

Antithrombotic therapy in atrial flutter: To anticoagulate or not, that is the question

Wesołek, F., Szyszka, P., Cichoń, M., Mizia­‐Stec, K., & Wybraniec, M. T. (2024) · Heart Rhythm O2 · doi:10.1016/j.hroo.2024.11.003 · Cited by 2 · see citing works

Fibrinogen, viscosity, and white blood cell count.

Ernst, E. (1992) · Circulation · doi:10.1161/circ.85.5.1572056 · Cited by 2 · see citing works

The Effects of a Bidirectional Cavo-Tricuspid Isthmus Block in Persistent Atrial Fibrillation

Kim, J., Choi, S., Joung, B., Lee, M., & Kim, S. S. (2011) · Yonsei Medical Journal · doi:10.3349/ymj.2012.53.1.76 · Cited by 1 · see citing works

Ablacja cieśni trójdzielno-żylnej wśród pacjentów z przetrwałym migotaniem przedsionków jako terapia pomostowa celem utrzymania rytmu zatokowego — badanie pilotażowe

Adamowicz, J., Szponder, M., Sokołowska, M., Sławuta, A., Gajek, J. J., & Zyśko, D. (2017) · Folia Cardiologica · doi:10.5603/fc.2017.0051 · Cited by 1 · see citing works

The characteristics of pre‐excitation syndrome concomitant with atrial tachyarrhythmia and the effect of radiofrequency ablation

Cui, C., Li, Z., Ju, W., Yang, G., Gu, K., Liu, H., Li, M., Chen, H., Wang, J., & Chen, M. (2022) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14598 · Cited by 1 · see citing works

Wide QRS complex tachycardia with a mysterious mask—Tricuspid isthmus‐dependent atrial flutter with preexcitation syndrome and dual atrioventricular nodal pathway conduction

Liu, C., Li, C., Xu, X., Zhou, M., Huang, X., Zhou, B., Cao, J., Huang, S., & Guo, Z. (2023) · Clinical Case Reports · doi:10.1002/ccr3.8202 · Cited by 1 · see citing works

Trends in Management of Atrial Fibrillation

Kerr, C. R., Yeung‐Lai‐Wah, J. A., & Leather, R. A. (1992) · Springer eBooks · doi:10.1007/978-3-662-30492-1_7 · Cited by 1 · see citing works

Hybrid pharmacological and ablative therapy for the management of symptomatic atrial fibrillation.

Kimman, G. P., Szili‐Törok, T., Nieuwdorp, M., Theuns, D. A. M. J., SCHOLTEN, M. F., & Jordaens, L. J. L. M. (2002) · PubMed Central · Cited by 1 · see citing works

Hybrid theraphy for atrial fibrillation

Geelen, P. (2000) · European Heart Journal · doi:10.1053/euhj.1999.1976 · Cited by 1 · see citing works

Acute Termination of Atrial Flutter: Are New Class Antiarrhythmic Drugs the Best Choice?

Baldi, N., Russo, V., Morrone, V., Gregorio, L. D., Liconso, L., & Polimeni, G. (2002) · Springer eBooks · doi:10.1007/978-88-470-2103-7_43

Baseline drug history is also important for interpretation of the electrocardiogram

Jolobe, O. M. P. (2010) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2010.04.009

Clinical Efficacy of Bepridil for Class I Antiarrhythmic Drug-Induced Atrial Flutter in Patients with Paroxysmal Atrial Fibrillation

Hayashi, H., Sumiyoshi, M., Suwa, S., Sakurai, H., Kawano, Y., Sekita, G., Tokano, T., Nakazato, Y., & Daida, H. (2008) · Journal of Arrhythmia · doi:10.1016/s1880-4276(08)80011-7

Elektrophysiologische Grundlagen der Hybrid-Therapie: Wie kommt es zur Konversion von Vorhofflimmern in Vorhofflattern?

Schumacher, B. M., & Neuser, H. (2003) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-003-0367-8

Atrial Flutter with 1:1 Atrioventricular Conduction Caused by Propafenone

EL‐HARARI, M. B., & Adams, P. C. (1998) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1998.tb00022.x · Cited by 22 · see citing works

Rapid Ventricular Response Due to Treatment of Atrial Flutter or Fibrillation with Class IC Antiarrhythmic Drugs

Mackstaller, L. L., & Marcus, G. M. (2000) · Annals of Noninvasive Electrocardiology · doi:10.1111/j.1542-474x.2000.tb00254.x · Cited by 7 · see citing works

[Proarrhythmic effect of propafenone in patients with atrial fibrillation and atrial flutter].

Jastrzębski, M. (2008) · PubMed · Cited by 4 · see citing works

[Persistent atrial flutter induced by propafenone (Rytmonorm)].

Fazekas, T., Kiss, J., Pap, I., & Rudas, L. (1994) · PubMed · Cited by 3 · see citing works

[Efficacy of intravenous propafenone in the management of arterial flutter and fibrillation of recent onset].

Minutiello, L. (1994) · PubMed · Cited by 1 · see citing works